The future of CTC research looks promising, with ongoing advancements in detection technologies and analytical methods. Researchers are exploring the use of single-cell sequencing to gain deeper insights into the genetic makeup of CTCs. Furthermore, combining CTC analysis with other biomarkers could enhance the accuracy of cancer diagnosis and prognosis. As our understanding of CTCs grows, they are likely to become an integral part of cancer management and treatment.
